Ulcerative colitis (UC) is one of the most severe chronic diseases, causing relentless gastrointestinal pain and ...

Based on the currently available funds and the expected reimbursement of the research tax credits (CIR) from 2024 in the second half of 2025 amounting to EUR 5.7M, Abivax expects to be able to finance ...

Ulcerative colitis (UC) is one of the two major types of chronic inflammatory bowel diseases (IBD), along with Crohn’s disease. UC affects the large bowel, has no known cure, and requires lifelong ...

Alvotech (NASDAQ:ALVO – Get Free Report) is expected to issue its quarterly earnings data after the market closes on ...

When 30-year-old Ella Rhian set off on a dream vacation across Vietnam and Bali, she never imagined a simple meal would alter ...

EQS-News: ABIVAX / Key word (s): Annual Results Abivax Announces Full Year 2024 Financial Results 24.03.2025 / 08:30 CET/CEST The issuer is solely responsible for the content of this announcement.

The following is a summary of "Treatment Sequencing in Inflammatory Bowel Disease: Towards Clinical Precision Medicine," published in the March 2025 issue of Best Practice & Research Clinical ...

Almost half of people who died with inflammatory bowel disease (IBD) died prematurely, according to a study published in the ...

A few months later, Ava was diagnosed with ulcerative colitis, a one-in-200 autoimmune condition that causes inflammation and ulcers in the lining of the colon and rectum. The teen's hair soon ...

Tremfya is also approved to treat patients with plaque psoriasis, active psoriatic arthritis and ulcerative colitis and is ...

The trial’s primary objective is to assess PALI-2108’s tolerability, pharmacokinetics and safety in healthy volunteers.